BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25324900)

  • 1. Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.
    Allen M; Kachadoorian M; Quicksall Z; Zou F; Chai HS; Younkin C; Crook JE; Pankratz VS; Carrasquillo MM; Krishnan S; Nguyen T; Ma L; Malphrus K; Lincoln S; Bisceglio G; Kolbert CP; Jen J; Mukherjee S; Kauwe JK; Crane PK; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Parisi JE; Petersen RC; Graff-Radford NR; Dickson DW; Younkin SG; Ertekin-Taner N
    Alzheimers Res Ther; 2014; 6(4):39. PubMed ID: 25324900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
    Strickland SL; Reddy JS; Allen M; N'songo A; Burgess JD; Corda MM; Ballard T; Wang X; Carrasquillo MM; Biernacka JM; Jenkins GD; Mukherjee S; Boehme K; Crane P; Kauwe JS; Ertekin-Taner N;
    Alzheimers Dement; 2020 Jul; 16(7):983-1002. PubMed ID: 32400971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease.
    Abraham R; Sims R; Carroll L; Hollingworth P; O'Donovan MC; Williams J; Owen MJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1152-5. PubMed ID: 19308965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Sánchez-Juan P; Moreno S; de Rojas I; Hernández I; Valero S; Alegret M; Montrreal L; García González P; Lage C; López-García S; Rodrííguez-Rodríguez E; Orellana A; Tárraga L; Boada M; Ruiz A
    Front Aging Neurosci; 2019; 11():327. PubMed ID: 31866851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
    Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
    JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating the Pick's disease International Consortium: Association study of
    Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Warner TT; Jaunmuktane Z; Boeve BF; Christopher EA; DeTure M; Duara R; Graff-Radford NR; Josephs KA; Knopman DS; Koga S; Murray ME; Lyons KE; Pahwa R; Parisi JE; Petersen RC; Whitwell J; Grinberg LT; Miller B; Schlereth A; Seeley WW; Spina S; Grossman M; Irwin DJ; Lee EB; Suh E; Trojanowski JQ; Van Deerlin VM; Wolk DA; Connors TR; Dooley PM; Frosch MP; Oakley DH; Aldecoa I; Balasa M; Gelpi E; Borrego-Écija S; de Eugenio Huélamo RM; Gascon-Bayarri J; Sánchez-Valle R; Sanz-Cartagena P; Piñol-Ripoll G; Molina-Porcel L; Bigio EH; Flanagan ME; Gefen T; Rogalski EJ; Weintraub S; Redding-Ochoa J; Chang K; Troncoso JC; Prokop S; Newell KL; Ghetti B; Jones M; Richardson A; Robinson AC; Roncaroli F; Snowden J; Allinson K; Green O; Rowe JB; Singh P; Beach TG; Serrano GE; Flowers XE; Goldman JE; Heaps AC; Leskinen SP; Teich AF; Black SE; Keith JL; Masellis M; Bodi I; King A; Sarraj SA; Troakes C; Halliday GM; Hodges JR; Kril JJ; Kwok JB; Piguet O; Gearing M; Arzberger T; Roeber S; Attems J; Morris CM; Thomas AJ; Evers BM; White CL; Mechawar N; Sieben AA; Cras PP; De Vil BB; De Deyn PPPP; Duyckaerts C; Le Ber I; Seihean D; Turbant-Leclere S; MacKenzie IR; McLean C; Cykowski MD; Ervin JF; Wang SJ; Graff C; Nennesmo I; Nagra RM; Riehl J; Kovacs GG; Giaccone G; Nacmias B; Neumann M; Ang LC; Finger EC; Blauwendraat C; Nalls MA; Singleton AB; Vitale D; Cunha C; Carvalho A; Wszolek ZK; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA
    medRxiv; 2023 Apr; ():. PubMed ID: 37163045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.
    Zhang CC; Zhu JX; Wan Y; Tan L; Wang HF; Yu JT; Tan L
    Oncotarget; 2017 Jul; 8(27):44994-45007. PubMed ID: 28402959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
    Mukherjee O; Kauwe JS; Mayo K; Morris JC; Goate AM
    BMC Genet; 2007 Jan; 8():3. PubMed ID: 17266761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPT haplotype diversity in multiple system atrophy.
    Labbé C; Heckman MG; Lorenzo-Betancor O; Murray ME; Ogaki K; Soto-Ortolaza AI; Walton RL; Fujioka S; Koga S; Uitti RJ; van Gerpen JA; Petersen RC; Graff-Radford NR; Younkin SG; Boeve BF; Cheshire WP; Low PA; Sandroni P; Coon EA; Singer W; Wszolek ZK; Dickson DW; Ross OA
    Parkinsonism Relat Disord; 2016 Sep; 30():40-5. PubMed ID: 27374978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
    Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
    Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
    J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
    Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
    Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype-specific expression of exon 10 at the human MAPT locus.
    Caffrey TM; Joachim C; Paracchini S; Esiri MM; Wade-Martins R
    Hum Mol Genet; 2006 Dec; 15(24):3529-37. PubMed ID: 17085483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MAPT H1 haplotype is associated with tangle-predominant dementia.
    Santa-Maria I; Haggiagi A; Liu X; Wasserscheid J; Nelson PT; Dewar K; Clark LN; Crary JF
    Acta Neuropathol; 2012 Nov; 124(5):693-704. PubMed ID: 22802095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
    Heckman MG; Kasanuki K; Brennan RR; Labbé C; Vargas ER; Soto AI; Murray ME; Koga S; Dickson DW; Ross OA
    Mov Disord; 2019 Sep; 34(9):1325-1332. PubMed ID: 31234228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate Overexpression of Tau in Drosophila Exacerbates Amyloid-β-Induced Neuronal Phenotypes and Correlates with Tau Oligomerization.
    Miguel L; Frebourg T; Campion D; Lecourtois M
    J Alzheimers Dis; 2020; 74(2):637-647. PubMed ID: 32065789
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Okunoye O; Ojo O; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
    medRxiv; 2023 Mar; ():. PubMed ID: 36993627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.
    Zhou F; Wang D
    Oncotarget; 2017 Jun; 8(26):43506-43520. PubMed ID: 28415654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age and the H1c MAPT haplotype on MAPT expression in human brain.
    Hayesmoore JB; Bray NJ; Cross WC; Owen MJ; O'Donovan MC; Morris HR
    Neurobiol Aging; 2009 Oct; 30(10):1652-6. PubMed ID: 18276036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.
    Labbé C; Heckman MG; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Murray ME; Allen M; Uitti RJ; Wszolek ZK; Smith GE; Kantarci K; Knopman DS; Lowe VJ; Jack CR; Ertekin-Taner N; Hassan A; Savica R; Petersen RC; Parisi JE; Maraganore DM; Graff-Radford NR; Ferman TJ; Boeve BF; Dickson DW; Ross OA
    Alzheimers Dement; 2016 Dec; 12(12):1297-1304. PubMed ID: 27287057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.